4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-003984
Chief Financial Officer sold 2,716 shares at $16.33 ($44,347)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRATES JAMES M Chief Financial Officer | 2024-01-09 | Sale | −2,716 | $16.33 | $44,347 | 112,035 | D |
| Open-market sales · 2,716 sh · avg $16.33 · $44,347 | |||||||
Loading xslF345X05/ownership.xml…